SEC Form 4 · accession 0001185185-16-003406
U.S. Stem Cell, Inc. · USRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William P Murphy Jr.
Director · 10% Owner
Period of report
Dec 28, 2015
Accepted (ET)
Jan 4, 2016 · 4:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388319
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 28, 2015 | C | 2,150 | — | A | 61,620 | D | |
| Common StockF2 | Dec 29, 2015 | C | 900 | — | A | 62,520 | D | |
| Common StockF3 | Dec 30, 2015 | C | 1,850 | — | A | 64,370 | D | |
| Common StockF4 | Dec 31, 2015 | C | 300 | — | A | 64,670 | D | |
| Common Stock | holding | — | — | — | 5,226 | I | Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1$0.7999 to $0.96
- F2$0.8996 to $0.985
- F3$0.8995 to $0.975
- F4$0.8994 to $0.95